Analysts Downgrade Sanofi Aventis Amid Long-Acting Insulin Concerns; Amylin Benefiting (SNY, AMLN, NVO)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. AMAT
2. SPY
3. RDDT
4. GLOB
5. WDAY
6. GNK
7. HTFL
8. SNDK
9. DVLT
10. ADYYF

Go back to Analysts Downgrade Sanofi Aventis Amid Long-Acting Insulin Concerns; Amylin Benefiting (SNY, AMLN, NVO)
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) Delayed: 30.98 --0 (-0%)
Previous Close $30.98    52 Week High $31.02 
Open $3.30    52 Week Low $8.03 
Day High $30.98    P/E N/A 
Day Low $30.98    EPS $-4.38 
Volume 440,704       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 45.89 --0 (-0%)
Previous Close $45.89    52 Week High $59.00 
Open $45.89    52 Week Low $32.80 
Day High $45.89    P/E N/A 
Day Low $45.89    EPS $0.00 
Volume 360,439       

SANOFI (NASDAQ: SNY) Delayed: 43.72 --0 (-0%)
Previous Close $43.72    52 Week High $44.76 
Open $43.72    52 Week Low $36.81 
Day High $43.72    P/E N/A 
Day Low $43.72    EPS $0.00 
Volume 4,426